References
- Enzinger F M, Weiss S W. Soft tissue tumors. St. CV Mosby, Louis 1983; 338–78
- Om A, Ghose T. Use of anti-skeletal muscle antibody from myasthenic patients in the diagnosis of childhood rhabdomyosarcomas. Am J Surg Pathol 1987; 11: 272–6
- de Jong A SH, van Kessel-van Vark M, Albus-Lutter C E. Pleomorphic rhabdomyosarcoma in adults: Immunohistochemistry as a tool for its diagnosis. Hum Pathol 1987; 18: 298–303
- Henderson D W, Raven J L, Pollard J A, Walters M N-I. Bone marrow metastases in disseminated alveolar rhabdomyosarcoma: Case report with ultrastructural study and review. Pathology 1976; 8: 329–41
- Nunez C, Abboud S L, Lemon N C, Kemp J A. Ovarian rhabdomyosarcoma presenting as leukemia. Cancer 1983; 52: 297–300
- Almanaseer I Y, Trujillo Y P, Taxy J B, Okuno T. Systemic rhabdomyosarcoma with diffuse bone marrow involvement. Am J Clin Pathol 1984; 82: 349–53
- Patton R B, Horn R C. Rhabdomyosarcoma: Clinical and pathological features and comparison with human fetal and embryonal skeletal muscle. Surgery 1962; 52: 572–84
- Mukai K, Rosai J, Hallaway B E. Localization of myoglobin in normal and neoplastic human skeletal muscle cells using an immunoperoxidase method. Am J Surg Pathol 1979; 3: 373–6
- de Jong A SH, van Kessel-van Vark M, Albus-Lutter C E. Skeletal muscle actin as tumor marker in the diagnosis of rhabdomyosarcoma in childhood. Am J Surg Pathol 1985; 9: 467–74
- Osborn M, Hill C, Aetmannsberger M, Weber K. Monoclonal antibodies to titin in conjunction with antibodies to desmin separate rhabdomyosarcomas from other tumor types. Lab Invest 1986; 55: 101–8
- Eusebi V, Ceccarelli C, Gorza L, et al. Immunocyotchemistry of rhabdomyosarcoma. The use of four different markers. Am J Surg Pathol 1986; 10: 293–9
- Castleman B. In: Case Records of the Massachusetts General Hospital. Case 4–1972. N Engl J Med 1972; 286: 205–12
- Ruymann F B, Newton W A, Ragab A H, et al. Bone marrow metastases at diagnosis in children and adolescents with rhabdomyosarcoma. Cancer 1984; 53: 368–73
- de la Serna F J, Martinez M A, Valdes M D, et al. Rhabdomyosarcoma presenting with diffuse bone marrow involvement, hypercalcemia and renal failure. Med Ped Oncol 1988; 16: 123–7
- Cho K R, Olson J L, Epstein J I. Primitive rhabdomyosarcoma presenting with diffuse bone marrow involvement: An immuno-histochemical and ultrastructural study. Mod Pathol 1988; 1: 23–8
- Ng C S, Chan J KC, Lo S TH. Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum Pathol 1987; 18: 1257–62
- Gazdar A F. Expression of neuroendocrine markers of lung cancers and other human tumors. Recent progress in clinical immunology and the application of monoclonal antibodies. Second annual symposium, Coulter Immunology. 1986; 26
- Rusthoven J J, Robinson J B, Kolin A, Pinkerton P H. The natural-killer-cell-associated HNK-1 (Leu-7) antibody reacts with hypertrophic and malignant prostatic epithelium. Cancer 1985; 56: 289–93
- Tsutsumi Y. Leu7 immunoreactivity as histochemical marker for paraffin-embedded neuroendocrine tumors. Acta Histochem Cytochem 1984; 17: 15–21
- Kwaguchi K, Kolike M. Neuron-specific enolase and Leu-7 immunoreactive small round-cell neoplasm. The relationship to Ewing's Sarcoma in bone and soft tissue. Am J Clin Pathol 1986; 86: 79–83
- Kemstead J T, Bicknell D, Greaves M F. A monoclonal antibody detecting an antigen shared by neural and granulocytic cells. Pediatr Res 1981; 15: 1282–6
- Kemstead J T, Fritschy J, Asser U, et al. Monoclonal antibodies defining markers with apparent selectivity for particular hemopoietic cell types may also detect antigens on cells of neural crest origin. Hybridoma 1982; 1: 109–23
- Patterson B J, Robinson J B, Pinkerton P H. Hemopoietic cell surface markers on metastatic small cell carcinoma detected with monoclonal antibodies. Am J Clin Pathol 1985; 84: 159–65